Dear SBIR Insider,
Our new year starts with a significantly new congress, new leadership in the House, new challenges, and of course, the Tucson tragedy. Our hearts go out to all the victims and their families, and there's little I can say that hasn't already been expressed.
The main topic for us now is to keep the SBIR/STTR programs alive as they approach their January 31, 2011 expiration date. In the final hours of the 111th congress, a compromise SBIR/STTR Reauthorization bill was passed in the Senate but ran out of time in the House.
The Senate Committee on Small Business and Entrepreneurship (SBE) under the leadership of its chair, Mary Landrieu (D-LA) and ranking member Olympia Snowe (R-ME) worked their hearts out to broker a compromise on an 8 year SBIR reauthorization. Their staff worked tirelessly to strike a compromise between the two major opposing factions, the Small Business Technology Council (SBTC) and the Biotechnology Industry Organization (BIO). Amazingly, for the first time ever, a compromise was achieved and agreed to by both sides, and the SBIR reauthorization bill, S.4053 was passed in the Senate.
With little time remaining on the last day of congress, the House Small Business Committee (SBC) did nothing but block the Senate's efforts. They were not in support of this bill.
In this new 112th Congress, we have a stable SBE, but lose Senators Kit Bond (R-MO) and Evan Bayh (D-IN) who chose to retire from the Senate. Both were strong SBIR supporters and we will miss them. In the House, we have a new chair in the form of Sam Graves (R-MO), who has been the ranking member of the SBC, and tended to shadow and support Nydia Velazquez (D-NY), former chair, now ranking member of the committee.
The question is: "Where do we go from here?" Read on.